Related Experiment Videos

Inadvertent administration of 480 mg/m2 of cisplatin

J H Schiller¹, J Rozental, K D Tutsch

¹University of Wisconsin Clinical Cancer Center, Madison 53792.

The American Journal of Medicine

|May 1, 1989

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung cancer: a trial of the ECOG-ACRIN Cancer Research Group (E3508).

Annals of oncology : official journal of the European Society for Medical Oncology·2017

A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

Randomised phase II study of axitinib or bevacizumab combined with paclitaxel/carboplatin as first-line therapy for patients with advanced non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Dosing to rash: a phase II trial of the first-line erlotinib for patients with advanced non-small-cell lung cancer an Eastern Cooperative Oncology Group Study (E3503).

European journal of cancer (Oxford, England : 1990)·2013

Baseline tumour measurements predict survival in advanced non-small cell lung cancer.

British journal of cancer·2013

A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer.

Cancer chemotherapy and pharmacology·2013

See all related articles